11 results on '"Shreay S"'
Search Results
2. Characterizing compensated cirrhosis (CC) patients with potential etiology of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH): findings from large Italian administrative databases.
3. Real World Treatment Patterns In Chronic Lymphocytic Leukemia Patients In The United States - Rituximab, The Most Commonly Used Agent.
4. Budget Impact Analysis Of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week For Cancer Patients Receiving Chemotherapy From A Us Payer's Perspective.
5. Efficiency of dialysis centers in the united states: An updated examination of facility characteristics that influence production of dialysis treatments.
6. PCN102 SYNCHRONIZATION OF ADMINISTRATIONS OF CHEMOTHERAPY AND ERYTHROPOIESIS-STIMULATING AGENTS AND FREQUENCY OF ASSOCIATED HEALTH CARE VISITS
7. CO72 Investigating Regional Differences in Cardiovascular Outcomes Among Patients Diagnosed with Hypertrophic Cardiomyopathy.
8. P3 Longitudinal Analyses of Healthcare Resource Utilization and Costs Among Patients with Obstructive Hypertrophic Cardiomyopathy.
9. CO184 US Population Burden of Acute Heart Failure Events and Hospitalization in Patients with Recent Worsening Heart Failure and Left Ventricular Ejection Fraction ≤30%.
10. EE620 Increase in HCM-Related Economic Burden Due to Atrial Fibrillation in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Analysis of 9490 Patients.
11. Health Economics And Outcomes Data Requirements In Indolent Non Hodgkins Lymphoma (Inhl) And Chronic Lymphocytic Leukemia (Cll) From United States Payer Perspective.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.